ACHV
Achieve Life Sciences Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| 11-07-2018 after market close | 08-08-2018 after market close | 05-09-2018 | 03-01-2018 | 11-09-2017 | 07-31-2017 | |
|---|---|---|---|---|---|---|
| Actual EPS | -0.71 | -1.82 | -0.24 | -0.32 | -0.9 | -0.1 |
| Consensus EPS | ||||||
| Estimated EPS | ||||||
| Number of Estimates | ||||||
| EPS Surprise |
Stats
Summary
Achieve Life Sciences Inc is a specialty pharmaceutical company. The company is developing cytisine as a smoking cessation aid. The cytisine is a plant-based alkaloid with a high binding affinity to the nicotinic acetylcholine receptor.
Market Cap: 22.6 Million
Primary Exchange: NASDAQ Capital Market
Website: http://www.achievelifesciences.com
Shares Outstanding: 11.9 Million
Float: 9.35 Million
Dividend: 0.0 (0.0%)
Beta: 2.271952
Sector: Healthcare
Industry: Biotechnology
Short Interest (Jan 12, 2018): 189 Thousand
Ethical Flags
Longest drawdown: 1243 trading days
From: 2014-03-10 To: 2019-02-20
Lowest Point:
Achieve completes enrollment in mid-stage study of smoking cessation candidate cytisinicline
via: SeekingAlpha at 2019-02-20 11:37:04:000
Achieve Life Sciences ( ACHV -1.5% ) has completed the enrollment of 254 subjects in a Phase 2b clinical trial, ORCA-1 , evaluating cytisinicline, plus behavioral support, for smoking cessation. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Read more … read more...
Achieve completes enrollment in mid-stage study of smoking cessation candidate cytisinicline
via: SeekingAlpha at 2019-02-20 11:37:04:000
Achieve Life Sciences ( ACHV -1.5% ) has completed the enrollment of 254 subjects in a Phase 2b clinical trial, ORCA-1 , evaluating cytisinicline, plus behavioral support, for smoking cessation. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Read more … read more...
Achieve Life Sciences Announces Completion of Enrollment in 254-Subject Phase 2b Trial of Cytisinicline for Smoking Cessation
via: PR Newswire at 2019-02-20 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , Feb. 20, 2019 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced the completi… read more...
Achieve Life Sciences Announces Completion of Enrollment in 254-Subject Phase 2b Trial of Cytisinicline for Smoking Cessation
via: PR Newswire at 2019-02-20 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , Feb. 20, 2019 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced the completi… read more...
SSYS, ARRY among premarket gainers
via: SeekingAlpha at 2019-01-15 09:16:52:000
Kitov Pharma (NASDAQ: KTOV ) +60% on new findings from its ongoing collaboration with researchers from the Hebrew University ofJerusalem revealingNT219s high affinity and selective binding to its target proteins. More news on: Kitov Pharmaceuticals Holdings… read more...
SSYS, ARRY among premarket gainers
via: SeekingAlpha at 2019-01-15 09:16:52:000
Kitov Pharma (NASDAQ: KTOV ) +60% on new findings from its ongoing collaboration with researchers from the Hebrew University ofJerusalem revealingNT219s high affinity and selective binding to its target proteins. More news on: Kitov Pharmaceuticals Holdings… read more...
SSYS, ARRY among premarket gainers
via: SeekingAlpha at 2019-01-15 09:16:52:000
Kitov Pharma (NASDAQ: KTOV ) +60% on new findings from its ongoing collaboration with researchers from the Hebrew University ofJerusalem revealingNT219s high affinity and selective binding to its target proteins. More news on: Kitov Pharmaceuticals Holdings… read more...
Achieve Announces Update on Cytisinicline Clinical Development Program
via: PR Newswire at 2018-12-18 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , Dec. 18, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today provided a clinical de… read more...
Achieve Announces Update on Cytisinicline Clinical Development Program
via: PR Newswire at 2018-12-18 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , Dec. 18, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today provided a clinical de… read more...
Achieve Announces Update on Cytisinicline Clinical Development Program
via: PR Newswire at 2018-12-18 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , Dec. 18, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today provided a clinical de… read more...
Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q3 2018 Results - Earnings Call Transcript
via: SeekingAlpha at 2018-11-07 22:49:31:000
Achieve Life Sciences, Inc. (ACHV) Q3 2018 Earnings Conference Call November 07, 2018, 04:30 PM ET Executives Jaime Welch - EVP, Commercial Richard Stewart - Chairman and CEO John Bencich - EVP, CFO and Operating Officer Cindy Jacobs - EVP and Chief Medical Officer Analysts … read more...
Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q3 2018 Results - Earnings Call Transcript
via: SeekingAlpha at 2018-11-07 22:49:31:000
Achieve Life Sciences, Inc. (ACHV) Q3 2018 Earnings Conference Call November 07, 2018, 04:30 PM ET Executives Jaime Welch - EVP, Commercial Richard Stewart - Chairman and CEO John Bencich - EVP, CFO and Operating Officer Cindy Jacobs - EVP and Chief Medical Officer Analysts … read more...
Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q3 2018 Results - Earnings Call Transcript
via: SeekingAlpha at 2018-11-07 22:49:31:000
Achieve Life Sciences, Inc. (ACHV) Q3 2018 Earnings Conference Call November 07, 2018, 04:30 PM ET Executives Jaime Welch - EVP, Commercial Richard Stewart - Chairman and CEO John Bencich - EVP, CFO and Operating Officer Cindy Jacobs - EVP and Chief Medical Officer Analysts … read more...
Achieve Life Sciences reports Q3 results
via: SeekingAlpha at 2018-11-07 16:22:27:000
Achieve Life Sciences (NASDAQ: ACHV ): Q3 GAAP EPS of -$0.71. More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Achieve Reports Financial Results for Third Quarter 2018 and Provides Cytisinicline (Cytisine) Clinical Development Update
via: PR Newswire at 2018-11-07 16:05:00:000
SEATTLE and VANCOUVER, British Columbia , Nov. 7, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today provided an update on t… read more...
Achieve Life Sciences to Announce Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018
via: PR Newswire at 2018-10-31 05:30:00:000
SEATTLE, Wash. and VANCOUVER, British Columbia , Oct. 31, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline (cytisine) for smoking cessation, today anno… read more...
Achieve Life Sciences to Announce Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018
via: PR Newswire at 2018-10-31 05:30:00:000
SEATTLE, Wash. and VANCOUVER, British Columbia , Oct. 31, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline (cytisine) for smoking cessation, today anno… read more...
Achieve Life Sciences to Announce Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018
via: PR Newswire at 2018-10-31 05:30:00:000
SEATTLE, Wash. and VANCOUVER, British Columbia , Oct. 31, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline (cytisine) for smoking cessation, today anno… read more...
Strong earnings lead stocks higher premarket
via: SeekingAlpha at 2018-10-30 09:16:31:000
Electro Scientific (NASDAQ: ESIO ) +87% on Q2 result . More news on: Electro Scientific Industries, Inc., Achieve Life Sciences, Inc., Differential Brands Group Inc., Stocks on the move, , Top stock market news, Read more … read more...
Achieve Life Sciences launches mid-stage study of cytisinicline for smoking cessation; shares up 28% premarket
via: SeekingAlpha at 2018-10-30 08:21:18:000
Nano cap Achieve Life Sciences (NASDAQ: ACHV ) is up 28% premarket on above-average volume in response to its launch of a Phase 2 clinical trial, ORCA-1 , evaluating cytisinicline (cytisine) for smoking cessation. More news on: Achieve Life Sciences, Inc., Healthcare stocks … read more...
Achieve Life Sciences Announces Initiation of Phase 2b ORCA-1 Trial Evaluating Cytisinicline (cytisine) for Smoking Cessation
via: PR Newswire at 2018-10-30 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , Oct. 30, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced initiation… read more...
Midday Gainers / Losers (10/01/2018)
via: SeekingAlpha at 2018-10-01 12:40:08:000
Gainers: OGEN +51% . LEVB +37% . NBEV +39% . ARCW +30% . NTGN +27% . IGC +25% . IFMK +24% . ACST +21% . ATLC +21% . ALT +21% . More news on: Oragenics, Inc., Level Brands, Inc., New Age Beverages Corporation, Stocks on the move, , Read more … read more...
Midday Gainers / Losers (10/01/2018)
via: SeekingAlpha at 2018-10-01 12:40:08:000
Gainers: OGEN +51% . LEVB +37% . NBEV +39% . ARCW +30% . NTGN +27% . IGC +25% . IFMK +24% . ACST +21% . ATLC +21% . ALT +21% . More news on: Oragenics, Inc., Level Brands, Inc., New Age Beverages Corporation, Stocks on the move, , Read more … read more...
Midday Gainers / Losers (10/01/2018)
via: SeekingAlpha at 2018-10-01 12:40:08:000
Gainers: OGEN +51% . LEVB +37% . NBEV +39% . ARCW +30% . NTGN +27% . IGC +25% . IFMK +24% . ACST +21% . ATLC +21% . ALT +21% . More news on: Oragenics, Inc., Level Brands, Inc., New Age Beverages Corporation, Stocks on the move, , Read more … read more...
Achieve Announces Pricing of $5.6 Million Registered Direct Offering
via: PR Newswire at 2018-10-01 09:05:00:000
SEATTLEand VANCOUVER, British Columbia , Oct. 1, 2018 /PRNewswire/ --Achieve Life Sciences,Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that it ha… read more...
Achieve Announces Pricing of $5.6 Million Registered Direct Offering
via: PR Newswire at 2018-10-01 09:05:00:000
SEATTLEand VANCOUVER, British Columbia , Oct. 1, 2018 /PRNewswire/ --Achieve Life Sciences,Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that it ha… read more...
Achieve Announces Pricing of $5.6 Million Registered Direct Offering
via: PR Newswire at 2018-10-01 09:05:00:000
SEATTLEand VANCOUVER, British Columbia , Oct. 1, 2018 /PRNewswire/ --Achieve Life Sciences,Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that it ha… read more...
Midday Gainers / Losers (09/27/2018)
via: SeekingAlpha at 2018-09-27 12:40:42:000
Gainers: ACHV +58% . RXII +36% . IGC +26% . GBR +25% . HAIR +20% . YGYI +18% . NTGN +17% . LQDA +16% . ARAY +17% . CCJ +16% . More news on: Achieve Life Sciences, Inc., RXI Pharmaceuticals Corporation, India Globalization Capital, Inc, Stocks on the mo… read more...
Midday Gainers / Losers (09/27/2018)
via: SeekingAlpha at 2018-09-27 12:40:42:000
Gainers: ACHV +58% . RXII +36% . IGC +26% . GBR +25% . HAIR +20% . YGYI +18% . NTGN +17% . LQDA +16% . ARAY +17% . CCJ +16% . More news on: Achieve Life Sciences, Inc., RXI Pharmaceuticals Corporation, India Globalization Capital, Inc, Stocks on the mo… read more...
Midday Gainers / Losers (09/27/2018)
via: SeekingAlpha at 2018-09-27 12:40:42:000
Gainers: ACHV +58% . RXII +36% . IGC +26% . GBR +25% . HAIR +20% . YGYI +18% . NTGN +17% . LQDA +16% . ARAY +17% . CCJ +16% . More news on: Achieve Life Sciences, Inc., RXI Pharmaceuticals Corporation, India Globalization Capital, Inc, Stocks on the mo… read more...
Premarket Gainers as of 9:05 am (09/27/2018)
via: SeekingAlpha at 2018-09-27 09:11:59:000
ACHV +35% on performance of new cytisine formulation. More news on: Achieve Life Sciences, Inc., Cameco Corporation, India Globalization Capital, Inc, Stocks on the move, Top stock market news, , Read more … read more...
Premarket Gainers as of 9:05 am (09/27/2018)
via: SeekingAlpha at 2018-09-27 09:11:59:000
ACHV +35% on performance of new cytisine formulation. More news on: Achieve Life Sciences, Inc., Cameco Corporation, India Globalization Capital, Inc, Stocks on the move, Top stock market news, , Read more … read more...
Premarket Gainers as of 9:05 am (09/27/2018)
via: SeekingAlpha at 2018-09-27 09:11:59:000
ACHV +35% on performance of new cytisine formulation. More news on: Achieve Life Sciences, Inc., Cameco Corporation, India Globalization Capital, Inc, Stocks on the move, Top stock market news, , Read more … read more...
Achieve Life Sciences up 38% premarket on performance of new cytisine formulation
via: SeekingAlpha at 2018-09-27 07:55:50:000
Nano cap Achieve Life Sciences (NASDAQ: ACHV ) is up 38% premarket on increased volume in response to its announcement that a new formulation of smoking cessation candidate cytisine demonstrated bioequivalence in healthy volunteer smokers with or without food. The results were … read more...
Achieve Life Sciences up 38% premarket on performance of new cytisine formulation
via: SeekingAlpha at 2018-09-27 07:55:50:000
Nano cap Achieve Life Sciences (NASDAQ: ACHV ) is up 38% premarket on increased volume in response to its announcement that a new formulation of smoking cessation candidate cytisine demonstrated bioequivalence in healthy volunteer smokers with or without food. The results were … read more...
Achieve Life Sciences up 38% premarket on performance of new cytisine formulation
via: SeekingAlpha at 2018-09-27 07:55:50:000
Nano cap Achieve Life Sciences (NASDAQ: ACHV ) is up 38% premarket on increased volume in response to its announcement that a new formulation of smoking cessation candidate cytisine demonstrated bioequivalence in healthy volunteer smokers with or without food. The results were … read more...
Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability for a New Cytisine Formulation in Fed and Fasted Subjects
via: PR Newswire at 2018-09-27 05:30:00:000
SEATTLEand VANCOUVER, British Columbia , Sept. 27, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced results of a clini… read more...
Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability for a New Cytisine Formulation in Fed and Fasted Subjects
via: PR Newswire at 2018-09-27 05:30:00:000
SEATTLEand VANCOUVER, British Columbia , Sept. 27, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced results of a clini… read more...
Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability for a New Cytisine Formulation in Fed and Fasted Subjects
via: PR Newswire at 2018-09-27 05:30:00:000
SEATTLEand VANCOUVER, British Columbia , Sept. 27, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced results of a clini… read more...
Achieve to Present at the Ladenburg Thalmann 2018 Healthcare Conference on October 2, 2018
via: PR Newswire at 2018-09-26 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , Sept. 26, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that Rick Stewa… read more...
Midday Gainers / Losers (09/24/2018)
via: SeekingAlpha at 2018-09-24 12:35:13:000
Gainers: AMRN +233% . SAEX +153% . GBR +41% . JONE +27% . IPCI +26% . XON +23% . CRC +17% . AGTC +16% . PEIX +15% . ACHV +15% . More news on: Amarin Corporation PLC, SAExploration Holdings, Inc., New Concept Energy, Inc., , Stocks on the move, Top stoc… read more...
Midday Gainers / Losers (09/24/2018)
via: SeekingAlpha at 2018-09-24 12:35:13:000
Gainers: AMRN +233% . SAEX +153% . GBR +41% . JONE +27% . IPCI +26% . XON +23% . CRC +17% . AGTC +16% . PEIX +15% . ACHV +15% . More news on: Amarin Corporation PLC, SAExploration Holdings, Inc., New Concept Energy, Inc., , Stocks on the move, Top stoc… read more...
Achieve Life Sciences up 12% premarket on new cytisine data
via: SeekingAlpha at 2018-09-18 08:58:31:000
Nano cap Achieve Life Sciences (NASDAQ: ACHV ) is up 12% premarket on light volume on the heels of new data from an observational study in Russia for smoking cessation candidate cytisine. The results were just published in the International Journal of Drug Policy . More news… read more...
Achieve Life Sciences up 12% premarket on new cytisine data
via: SeekingAlpha at 2018-09-18 08:58:31:000
Nano cap Achieve Life Sciences (NASDAQ: ACHV ) is up 12% premarket on light volume on the heels of new data from an observational study in Russia for smoking cessation candidate cytisine. The results were just published in the International Journal of Drug Policy . More news… read more...
Achieve Life Sciences up 12% premarket on new cytisine data
via: SeekingAlpha at 2018-09-18 08:58:31:000
Nano cap Achieve Life Sciences (NASDAQ: ACHV ) is up 12% premarket on light volume on the heels of new data from an observational study in Russia for smoking cessation candidate cytisine. The results were just published in the International Journal of Drug Policy . More news… read more...
Achieve Announces Positive Cytisine Data Published in International Journal of Drug Policy
via: PR Newswire at 2018-09-18 05:30:00:000
SEATTLE, Wash. and VANCOUVER, British Columbia , Sept. 18, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced the publi… read more...
Achieve Announces Positive Cytisine Data Published in International Journal of Drug Policy
via: PR Newswire at 2018-09-18 05:30:00:000
SEATTLE, Wash. and VANCOUVER, British Columbia , Sept. 18, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced the publi… read more...
Achieve Announces Positive Cytisine Data Published in International Journal of Drug Policy
via: PR Newswire at 2018-09-18 05:30:00:000
SEATTLE, Wash. and VANCOUVER, British Columbia , Sept. 18, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced the publi… read more...
Achieve Life Sciences Announces Cytisine Data Presented at the Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Conference
via: PR Newswire at 2018-09-06 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , Sept. 6, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), today announced that cytisine data will be presented at the Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Conference , September 6-8 th in M… read more...
Achieve Life Sciences Announces Cytisine Data Presented at the Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Conference
via: PR Newswire at 2018-09-06 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , Sept. 6, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), today announced that cytisine data will be presented at the Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Conference , September 6-8 th in M… read more...
Achieve Life Sciences Announces Cytisine Data Presented at the Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Conference
via: PR Newswire at 2018-09-06 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , Sept. 6, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), today announced that cytisine data will be presented at the Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Conference , September 6-8 th in M… read more...
Achieve to Present at the H.C. Wainwright 20th Annual Global Investment Conference on September 6, 2018
via: PR Newswire at 2018-09-05 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , Sept. 5, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that John Bencich , C… read more...
Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q2 2018 Results - Earnings Call Transcript
via: SeekingAlpha at 2018-08-08 18:52:07:000
Achieve Life Sciences, Inc. (ACHV) Q2 2018 Results Earnings Conference Call August 08, 2018, 04:30 PM ET Executives Jaime Welch - Executive Vice President, Commercial Richard Stewart - Chairman and Chief Executive Officer John Bencich - Executive VP, CFO and Operating Officer A… read more...
Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q2 2018 Results - Earnings Call Transcript
via: SeekingAlpha at 2018-08-08 18:52:07:000
Achieve Life Sciences, Inc. (ACHV) Q2 2018 Results Earnings Conference Call August 08, 2018, 04:30 PM ET Executives Jaime Welch - Executive Vice President, Commercial Richard Stewart - Chairman and Chief Executive Officer John Bencich - Executive VP, CFO and Operating Officer A… read more...
Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q2 2018 Results - Earnings Call Transcript
via: SeekingAlpha at 2018-08-08 18:52:07:000
Achieve Life Sciences, Inc. (ACHV) Q2 2018 Results Earnings Conference Call August 08, 2018, 04:30 PM ET Executives Jaime Welch - Executive Vice President, Commercial Richard Stewart - Chairman and Chief Executive Officer John Bencich - Executive VP, CFO and Operating Officer A… read more...
Achieve Life Sciences reports Q2 results
via: SeekingAlpha at 2018-08-08 16:12:09:000
Achieve Life Sciences (NASDAQ: ACHV ): Q2 EPS of -$1.82 More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Achieve Life Sciences reports Q2 results
via: SeekingAlpha at 2018-08-08 16:12:09:000
Achieve Life Sciences (NASDAQ: ACHV ): Q2 EPS of -$1.82 More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Achieve Life Sciences reports Q2 results
via: SeekingAlpha at 2018-08-08 16:12:09:000
Achieve Life Sciences (NASDAQ: ACHV ): Q2 EPS of -$1.82 More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Achieve Reports Financial Results for Second Quarter 2018 and Provides Cytisine Clinical Development Update
via: PR Newswire at 2018-08-08 16:05:00:000
SEATTLE and VANCOUVER, British Columbia , Aug. 8, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today provided an update on the cytisin… read more...
Achieve Reports Financial Results for Second Quarter 2018 and Provides Cytisine Clinical Development Update
via: PR Newswire at 2018-08-08 16:05:00:000
SEATTLE and VANCOUVER, British Columbia , Aug. 8, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today provided an update on the cytisin… read more...
Achieve Reports Financial Results for Second Quarter 2018 and Provides Cytisine Clinical Development Update
via: PR Newswire at 2018-08-08 16:05:00:000
SEATTLE and VANCOUVER, British Columbia , Aug. 8, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today provided an update on the cytisin… read more...
Achieve Life Sciences to Release Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 8, 2018
via: PR Newswire at 2018-08-02 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , Aug. 2, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that it will repor… read more...
Achieve Life Sciences to Release Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 8, 2018
via: PR Newswire at 2018-08-02 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , Aug. 2, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that it will repor… read more...
Achieve Life Sciences to Release Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 8, 2018
via: PR Newswire at 2018-08-02 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , Aug. 2, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that it will repor… read more...
Your Daily Pharma Scoop: ResTORbio Progresses, Roche Closer To Review, AbbVie Falters
via: SeekingAlpha at 2018-07-13 04:16:50:000
Stocks in News: TORC, RHHBY ResTORbio's RTB101 shows treatment benefit in mid-stage study; shares up 9% Discussion : ResTORbio ( TORC ) announced positive results from a Phase 2a clinical trial of its lead drug RTB101 in elderly patients. The candidate was on trial testing its infecti… read more...
Your Daily Pharma Scoop: ResTORbio Progresses, Roche Closer To Review, AbbVie Falters
via: SeekingAlpha at 2018-07-13 04:16:50:000
Stocks in News: TORC, RHHBY ResTORbio's RTB101 shows treatment benefit in mid-stage study; shares up 9% Discussion : ResTORbio ( TORC ) announced positive results from a Phase 2a clinical trial of its lead drug RTB101 in elderly patients. The candidate was on trial testing its infecti… read more...
Your Daily Pharma Scoop: ResTORbio Progresses, Roche Closer To Review, AbbVie Falters
via: SeekingAlpha at 2018-07-13 04:16:50:000
Stocks in News: TORC, RHHBY ResTORbio's RTB101 shows treatment benefit in mid-stage study; shares up 9% Discussion : ResTORbio ( TORC ) announced positive results from a Phase 2a clinical trial of its lead drug RTB101 in elderly patients. The candidate was on trial testing its infecti… read more...
Your Daily Pharma Scoop: ResTORbio Progresses, Roche Closer To Review, AbbVie Falters
via: SeekingAlpha at 2018-07-13 04:16:50:000
Stocks in News: TORC, RHHBY ResTORbio's RTB101 shows treatment benefit in mid-stage study; shares up 9% Discussion : ResTORbio ( TORC ) announced positive results from a Phase 2a clinical trial of its lead drug RTB101 in elderly patients. The candidate was on trial testing its infecti… read more...
Your Daily Pharma Scoop: ResTORbio Progresses, Roche Closer To Review, AbbVie Falters
via: SeekingAlpha at 2018-07-13 04:16:50:000
Stocks in News: TORC, RHHBY ResTORbio's RTB101 shows treatment benefit in mid-stage study; shares up 9% Discussion : ResTORbio ( TORC ) announced positive results from a Phase 2a clinical trial of its lead drug RTB101 in elderly patients. The candidate was on trial testing its infecti… read more...
Midday Gainers / Losers (07/11/2018)
via: SeekingAlpha at 2018-07-11 12:42:53:000
Gainers: MDGS +79% . MYOS +42% . BIOC +28% . ACHV +24% . TKAT +18% . ACIU +15% . MYGN +15% . WMLP +14% . MTSL +14% . INTX +13% . More news on: Medigus Ltd, MYOS RENS Technology, Biocept, Inc., Stocks on the move, , Read more … read more...
Midday Gainers / Losers (07/11/2018)
via: SeekingAlpha at 2018-07-11 12:42:53:000
Gainers: MDGS +79% . MYOS +42% . BIOC +28% . ACHV +24% . TKAT +18% . ACIU +15% . MYGN +15% . WMLP +14% . MTSL +14% . INTX +13% . More news on: Medigus Ltd, MYOS RENS Technology, Biocept, Inc., Stocks on the move, , Read more … read more...
Premarket Gainers as of 9:05 am (07/11/2018)
via: SeekingAlpha at 2018-07-11 09:14:44:000
MTSL +53% . More news on: MER Telemanagement Solutions Ltd., Achieve Life Sciences, Inc., Asterias Biotherapeutics, Inc., Stocks on the move, Read more … read more...
Premarket Gainers as of 9:05 am (07/11/2018)
via: SeekingAlpha at 2018-07-11 09:14:44:000
MTSL +53% . More news on: MER Telemanagement Solutions Ltd., Achieve Life Sciences, Inc., Asterias Biotherapeutics, Inc., Stocks on the move, Read more … read more...
Achieve Life Sciences up 19% premarket on cytisine development plan
via: SeekingAlpha at 2018-07-11 06:54:48:000
Nano cap Achieve Life Sciences (NASDAQ: ACHV ) is up 19% premarket on light volume in response to its updated development plan for smoking cessation drug cytisine. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...
Achieve Life Sciences up 19% premarket on cytisine development plan
via: SeekingAlpha at 2018-07-11 06:54:48:000
Nano cap Achieve Life Sciences (NASDAQ: ACHV ) is up 19% premarket on light volume in response to its updated development plan for smoking cessation drug cytisine. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...
Achieve Life Sciences Announces Advancement of Cytisine Development Program Following Meeting with the FDA
via: PR Newswire at 2018-07-11 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , July 11, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced an update on the … read more...
Achieve Life Sciences Announces Advancement of Cytisine Development Program Following Meeting with the FDA
via: PR Newswire at 2018-07-11 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , July 11, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced an update on the … read more...
Your Daily Pharma Scoop: Glaukos And Achaogen Approvals, Puma Up On EU Prospects, FOLD Down
via: SeekingAlpha at 2018-06-28 08:00:00:000
Readers note: The Analysis Focus section is now only available to TPT subscribers . This follows the announcement from yesterday. Stocks in News: GKOS, AKAO Glaukos wins FDA approval for treatment managing glaucoma patients IOP Glaukos ( GKOS ) received FDA approval for it… read more...
Your Daily Pharma Scoop: Glaukos And Achaogen Approvals, Puma Up On EU Prospects, FOLD Down
via: SeekingAlpha at 2018-06-28 08:00:00:000
Readers note: The Analysis Focus section is now only available to TPT subscribers . This follows the announcement from yesterday. Stocks in News: GKOS, AKAO Glaukos wins FDA approval for treatment managing glaucoma patients IOP Glaukos ( GKOS ) received FDA approval for it… read more...
Your Daily Pharma Scoop: Glaukos And Achaogen Approvals, Puma Up On EU Prospects, FOLD Down
via: SeekingAlpha at 2018-06-28 08:00:00:000
Readers note: The Analysis Focus section is now only available to TPT subscribers . This follows the announcement from yesterday. Stocks in News: GKOS, AKAO Glaukos wins FDA approval for treatment managing glaucoma patients IOP Glaukos ( GKOS ) received FDA approval for it… read more...
Premarket Gainers as of 9:05 am (06/26/2018)
via: SeekingAlpha at 2018-06-26 09:18:33:000
LEE +46% on deal with Berkshire. More news on: Lee Enterprises, Incorporated, Achieve Life Sciences, Inc., Avinger, Stocks on the move, Read more … read more...
Premarket Gainers as of 9:05 am (06/26/2018)
via: SeekingAlpha at 2018-06-26 09:18:33:000
LEE +46% on deal with Berkshire. More news on: Lee Enterprises, Incorporated, Achieve Life Sciences, Inc., Avinger, Stocks on the move, Read more … read more...
Achieve Life Sciences +47% on results of smoking cessation aid studies
via: SeekingAlpha at 2018-06-26 08:36:03:000
Achieve Life Sciences (NASDAQ: ACHV ) +47.3% premarket after announcing positive results from a series of drug metabolism, drug-drug interaction and transporter studies with cytisine, its product candidate being evaluated as an aid to smoking cessation. More news on: Achieve Life Scien… read more...
Achieve Life Sciences +47% on results of smoking cessation aid studies
via: SeekingAlpha at 2018-06-26 08:36:03:000
Achieve Life Sciences (NASDAQ: ACHV ) +47.3% premarket after announcing positive results from a series of drug metabolism, drug-drug interaction and transporter studies with cytisine, its product candidate being evaluated as an aid to smoking cessation. More news on: Achieve Life Scien… read more...
Achieve Announces Positive Cytisine Data Demonstrating No Clinically Significant Drug-Drug Interaction
via: PR Newswire at 2018-06-26 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , June 26, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company, today announced positive results from a series of drug metabolism, drug-drug interaction and transporter studies with cytisin… read more...
Achieve Announces Positive Cytisine Data Demonstrating No Clinically Significant Drug-Drug Interaction
via: PR Newswire at 2018-06-26 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , June 26, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company, today announced positive results from a series of drug metabolism, drug-drug interaction and transporter studies with cytisin… read more...
Premarket Gainers as of 9:05 am (6/25/2018)
via: SeekingAlpha at 2018-06-25 09:23:50:000
XRM +101% on being acquired by Andritz AG. More news on: Xerium Technologies, Inc., Legacy Reserves LP Cum Red Perp Pfd Units Series B, Valeritas Holdings, Inc., Stocks on the move, Read more … read more...
Achieve Life Sciences, Inc. Announces Closing of a $13.8 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
via: PR Newswire at 2018-06-19 16:01:00:000
SEATTLE and VANCOUVER, British Columbia , June 19, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced the closing of an unde… read more...
Achieve Life Sciences, Inc. Announces Closing of a $13.8 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
via: PR Newswire at 2018-06-19 16:01:00:000
SEATTLE and VANCOUVER, British Columbia , June 19, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced the closing of an unde… read more...
Achieve Life Sciences, Inc. Announces Closing of a $13.8 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
via: PR Newswire at 2018-06-19 16:01:00:000
SEATTLE and VANCOUVER, British Columbia , June 19, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced the closing of an unde… read more...
Midday Gainers / Losers (06/15/2018)
via: SeekingAlpha at 2018-06-15 12:36:26:000
Gainers: CLPS +34% . GOOS +27% . NDRA +24% . BAK +19% . TPIV +19% . VSTM +16% . CFRX +15% . NETE +14% . TCI +14% . NEWA +13% . More news on: CLPS, Inc, Canada Goose Holdings, Endra Life Sciences Inc, Stocks on the move, , Read more … read more...
Midday Gainers / Losers (06/15/2018)
via: SeekingAlpha at 2018-06-15 12:36:26:000
Gainers: CLPS +34% . GOOS +27% . NDRA +24% . BAK +19% . TPIV +19% . VSTM +16% . CFRX +15% . NETE +14% . TCI +14% . NEWA +13% . More news on: CLPS, Inc, Canada Goose Holdings, Endra Life Sciences Inc, Stocks on the move, , Read more … read more...
Midday Gainers / Losers (06/15/2018)
via: SeekingAlpha at 2018-06-15 12:36:26:000
Gainers: CLPS +34% . GOOS +27% . NDRA +24% . BAK +19% . TPIV +19% . VSTM +16% . CFRX +15% . NETE +14% . TCI +14% . NEWA +13% . More news on: CLPS, Inc, Canada Goose Holdings, Endra Life Sciences Inc, Stocks on the move, , Read more … read more...
Midday Gainers / Losers (06/15/2018)
via: SeekingAlpha at 2018-06-15 12:36:26:000
Gainers: CLPS +34% . GOOS +27% . NDRA +24% . BAK +19% . TPIV +19% . VSTM +16% . CFRX +15% . NETE +14% . TCI +14% . NEWA +13% . More news on: CLPS, Inc, Canada Goose Holdings, Endra Life Sciences Inc, Stocks on the move, , Read more … read more...
Premarket Losers as of 9:05 am (6/15/2018)
via: SeekingAlpha at 2018-06-15 09:14:23:000
ACHV -28% on continued sell off. More news on: Achieve Life Sciences, Inc., Affimed Therapeutics, Destination Maternity Corporation, Stocks on the move, , Read more … read more...
Premarket Losers as of 9:05 am (6/15/2018)
via: SeekingAlpha at 2018-06-15 09:14:23:000
ACHV -28% on continued sell off. More news on: Achieve Life Sciences, Inc., Affimed Therapeutics, Destination Maternity Corporation, Stocks on the move, , Read more … read more...
Premarket Losers as of 9:05 am (6/15/2018)
via: SeekingAlpha at 2018-06-15 09:14:23:000
ACHV -28% on continued sell off. More news on: Achieve Life Sciences, Inc., Affimed Therapeutics, Destination Maternity Corporation, Stocks on the move, , Read more … read more...
Premarket Losers as of 9:05 am (6/15/2018)
via: SeekingAlpha at 2018-06-15 09:14:23:000
ACHV -28% on continued sell off. More news on: Achieve Life Sciences, Inc., Affimed Therapeutics, Destination Maternity Corporation, Stocks on the move, , Read more … read more...
Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering
via: PR Newswire at 2018-06-15 08:30:00:000
SEATTLE and VANCOUVER, British Columbia , June 15, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced the pricing of an… read more...
Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering
via: PR Newswire at 2018-06-15 08:30:00:000
SEATTLE and VANCOUVER, British Columbia , June 15, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced the pricing of an… read more...
Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering
via: PR Newswire at 2018-06-15 08:30:00:000
SEATTLE and VANCOUVER, British Columbia , June 15, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced the pricing of an… read more...
Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering
via: PR Newswire at 2018-06-15 08:30:00:000
SEATTLE and VANCOUVER, British Columbia , June 15, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced the pricing of an… read more...
Achieve Life Sciences continues selloff, down 13% premarket
via: SeekingAlpha at 2018-06-15 07:32:47:000
Thinly traded nano cap Achieve Life Sciences (NASDAQ: ACHV ) is down 13% premarket on light volume. Shares have sold off almost 65% since touching $14.60 on May 7. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Read more …. read more...
Achieve Life Sciences continues selloff, down 13% premarket
via: SeekingAlpha at 2018-06-15 07:32:47:000
Thinly traded nano cap Achieve Life Sciences (NASDAQ: ACHV ) is down 13% premarket on light volume. Shares have sold off almost 65% since touching $14.60 on May 7. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Read more …. read more...
Achieve Life Sciences continues selloff, down 13% premarket
via: SeekingAlpha at 2018-06-15 07:32:47:000
Thinly traded nano cap Achieve Life Sciences (NASDAQ: ACHV ) is down 13% premarket on light volume. Shares have sold off almost 65% since touching $14.60 on May 7. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Read more …. read more...
Achieve Life Sciences continues selloff, down 13% premarket
via: SeekingAlpha at 2018-06-15 07:32:47:000
Thinly traded nano cap Achieve Life Sciences (NASDAQ: ACHV ) is down 13% premarket on light volume. Shares have sold off almost 65% since touching $14.60 on May 7. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Read more …. read more...
Midday Gainers / Losers (06/14/2018)
via: SeekingAlpha at 2018-06-14 12:49:59:000
Gainers: AGMH +79% . FLKS +48% . ETSY +30% . DEST +27% . THST +26% . NITE +20% . DBX +18% . INSY +16% . CLPS +12% . LIVX +13% . More news on: AGM Group Holdings Inc., Flex Pharma, Etsy, Inc., Stocks on the move, , Read more … read more...
Achieve Announces Publication of Cytisine Data for Next-Generation Cytisine Molecules
via: PR Newswire at 2018-06-11 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , June 11, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that cytisine dat… read more...
Achieve Announces Publication of Cytisine Data for Next-Generation Cytisine Molecules
via: PR Newswire at 2018-06-11 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , June 11, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that cytisine dat… read more...
Achieve Announces Publication of Cytisine Data for Next-Generation Cytisine Molecules
via: PR Newswire at 2018-06-11 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , June 11, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that cytisine dat… read more...
Midday Gainers / Losers (05/24/2018)
via: SeekingAlpha at 2018-05-24 12:50:06:000
Gainers: CHCI +132% . SBOT +34% . UVV +28% . HDSN +20% . CATO +20% . DEST +18% . EOLS +17% . AXTI +16% . VIVE +15% . ACHV +13% . More news on: Comstock Homebuilding Companies, Inc., Stellar Biotechnologies Inc., Universal Corporation, Stocks on the move, , … read more...
Midday Gainers / Losers (05/24/2018)
via: SeekingAlpha at 2018-05-24 12:50:06:000
Gainers: CHCI +132% . SBOT +34% . UVV +28% . HDSN +20% . CATO +20% . DEST +18% . EOLS +17% . AXTI +16% . VIVE +15% . ACHV +13% . More news on: Comstock Homebuilding Companies, Inc., Stellar Biotechnologies Inc., Universal Corporation, Stocks on the move, , … read more...
Midday Gainers / Losers (05/24/2018)
via: SeekingAlpha at 2018-05-24 12:50:06:000
Gainers: CHCI +132% . SBOT +34% . UVV +28% . HDSN +20% . CATO +20% . DEST +18% . EOLS +17% . AXTI +16% . VIVE +15% . ACHV +13% . More news on: Comstock Homebuilding Companies, Inc., Stellar Biotechnologies Inc., Universal Corporation, Stocks on the move, , … read more...
Midday Gainers / Losers (05/24/2018)
via: SeekingAlpha at 2018-05-24 12:50:06:000
Gainers: CHCI +132% . SBOT +34% . UVV +28% . HDSN +20% . CATO +20% . DEST +18% . EOLS +17% . AXTI +16% . VIVE +15% . ACHV +13% . More news on: Comstock Homebuilding Companies, Inc., Stellar Biotechnologies Inc., Universal Corporation, Stocks on the move, , … read more...
Achieve Life Sciences, Inc. Announces Reverse Stock Split
via: PR Newswire at 2018-05-23 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , May 23, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced a reverse stock sp… read more...
Achieve Life Sciences, Inc. Announces Reverse Stock Split
via: PR Newswire at 2018-05-23 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , May 23, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced a reverse stock sp… read more...
Achieve Life Sciences, Inc. Announces Reverse Stock Split
via: PR Newswire at 2018-05-23 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , May 23, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced a reverse stock sp… read more...
Achieve Life Sciences, Inc. Announces Reverse Stock Split
via: PR Newswire at 2018-05-23 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , May 23, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced a reverse stock sp… read more...
Midday Gainers / Losers (05/11/2018)
via: SeekingAlpha at 2018-05-11 12:41:01:000
Gainers: ANFI +83% . HEAR +48% . TTD +40% . ARCB +28% . WOW +28% . OMER +24% . MOSY +24% . BOXL +20% . BLNK +20% . EOLS +17% . More news on: Amira Nature Foods, Turtle Beach Corporation, The Trade Desk, Stocks on the move, , Read more … read more...
Midday Gainers / Losers (05/11/2018)
via: SeekingAlpha at 2018-05-11 12:41:01:000
Gainers: ANFI +83% . HEAR +48% . TTD +40% . ARCB +28% . WOW +28% . OMER +24% . MOSY +24% . BOXL +20% . BLNK +20% . EOLS +17% . More news on: Amira Nature Foods, Turtle Beach Corporation, The Trade Desk, Stocks on the move, , Read more … read more...
Midday Gainers / Losers (05/11/2018)
via: SeekingAlpha at 2018-05-11 12:41:01:000
Gainers: ANFI +83% . HEAR +48% . TTD +40% . ARCB +28% . WOW +28% . OMER +24% . MOSY +24% . BOXL +20% . BLNK +20% . EOLS +17% . More news on: Amira Nature Foods, Turtle Beach Corporation, The Trade Desk, Stocks on the move, , Read more … read more...
Achieve Life Sciences reports Q1 results
via: SeekingAlpha at 2018-05-09 16:54:28:000
Achieve Life Sciences (NASDAQ: ACHV ): Q1 EPS of -$0.24 Cash, cash equivalents, short-term investments and restricted cash of $4.4M Press Release More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , read more...
Achieve Life Sciences reports Q1 results
via: SeekingAlpha at 2018-05-09 16:54:28:000
Achieve Life Sciences (NASDAQ: ACHV ): Q1 EPS of -$0.24 Cash, cash equivalents, short-term investments and restricted cash of $4.4M Press Release More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , read more...
Achieve Life Sciences reports Q1 results
via: SeekingAlpha at 2018-05-09 16:54:28:000
Achieve Life Sciences (NASDAQ: ACHV ): Q1 EPS of -$0.24 Cash, cash equivalents, short-term investments and restricted cash of $4.4M Press Release More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , read more...
Achieve Reports Financial Results for First Quarter 2018
via: PR Newswire at 2018-05-09 16:15:00:000
SEATTLE and VANCOUVER, British Columbia , May 9, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced first quarter 20… read more...
Achieve Reports Financial Results for First Quarter 2018
via: PR Newswire at 2018-05-09 16:15:00:000
SEATTLE and VANCOUVER, British Columbia , May 9, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced first quarter 20… read more...
Achieve Reports Financial Results for First Quarter 2018
via: PR Newswire at 2018-05-09 16:15:00:000
SEATTLE and VANCOUVER, British Columbia , May 9, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced first quarter 20… read more...
Achieve Announces Patent Granted on Novel Formulation of Cytisine
via: PR Newswire at 2018-05-07 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , May 7, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that the UK Intelle… read more...
Achieve Announces Patent Granted on Novel Formulation of Cytisine
via: PR Newswire at 2018-05-07 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , May 7, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that the UK Intelle… read more...
Achieve Announces Patent Granted on Novel Formulation of Cytisine
via: PR Newswire at 2018-05-07 05:30:00:000
SEATTLE and VANCOUVER, British Columbia , May 7, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that the UK Intelle… read more...
Achieve Life Sciences Announces Cytisine Symposium at the 17th World Conference on Tobacco or Health
via: PR Newswire at 2018-03-06 05:30:00:000
BOTHELL, Wash. and VANCOUVER, British Columbia , March 6, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), today announced that the World Conference on Tobacco or Health (WCTOH) will be holding a symposium on cytisine research at this year's annual conference, March 7-9… read more...
Achieve Life Sciences Announces Cytisine Symposium at the 17th World Conference on Tobacco or Health
via: PR Newswire at 2018-03-06 05:30:00:000
BOTHELL, Wash. and VANCOUVER, British Columbia , March 6, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), today announced that the World Conference on Tobacco or Health (WCTOH) will be holding a symposium on cytisine research at this year's annual conference, March 7-9… read more...
Achieve Life Sciences Announces Cytisine Symposium at the 17th World Conference on Tobacco or Health
via: PR Newswire at 2018-03-06 05:30:00:000
BOTHELL, Wash. and VANCOUVER, British Columbia , March 6, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), today announced that the World Conference on Tobacco or Health (WCTOH) will be holding a symposium on cytisine research at this year's annual conference, March 7-9… read more...
Achieve Life Sciences reports Q4 results
via: SeekingAlpha at 2018-03-01 17:00:23:000
Achieve Life Sciences (NASDAQ: ACHV ): Q4 EPS of -$0.32 More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Achieve Life Sciences reports Q4 results
via: SeekingAlpha at 2018-03-01 17:00:23:000
Achieve Life Sciences (NASDAQ: ACHV ): Q4 EPS of -$0.32 More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Achieve Life Sciences reports Q4 results
via: SeekingAlpha at 2018-03-01 17:00:23:000
Achieve Life Sciences (NASDAQ: ACHV ): Q4 EPS of -$0.32 More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Achieve Life Sciences reports Q4 results
via: SeekingAlpha at 2018-03-01 16:59:32:000
Achieve Life Sciences (NASDAQ: ACHV ): Q4 EPS of -$0.32 More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Achieve Life Sciences reports Q4 results
via: SeekingAlpha at 2018-03-01 16:59:32:000
Achieve Life Sciences (NASDAQ: ACHV ): Q4 EPS of -$0.32 More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Achieve Life Sciences reports Q4 results
via: SeekingAlpha at 2018-03-01 16:59:32:000
Achieve Life Sciences (NASDAQ: ACHV ): Q4 EPS of -$0.32 More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Achieve Announces Recent Highlights and Reports Year-End 2017 Financial Results
via: PR Newswire at 2018-03-01 16:30:00:000
BOTHELL, Wash. and VANCOUVER, British Columbia , March 1, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today highlighted recent accomp… read more...
Achieve Announces Recent Highlights and Reports Year-End 2017 Financial Results
via: PR Newswire at 2018-03-01 16:30:00:000
BOTHELL, Wash. and VANCOUVER, British Columbia , March 1, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today highlighted recent accomp… read more...
Achieve Announces Recent Highlights and Reports Year-End 2017 Financial Results
via: PR Newswire at 2018-03-01 16:30:00:000
BOTHELL, Wash. and VANCOUVER, British Columbia , March 1, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today highlighted recent accomp… read more...
Your Daily Pharma Scoop: Buy Heron At Dips, Aimmune Positive Data, Voyager And AbbVie Ink Deal
via: SeekingAlpha at 2018-02-21 08:00:00:000
Analysis of top Seeking Alpha coverage: Heron Therapeutics Today we will discuss Heron Therapeutics ( HRTX ), which got a boost last week after an FDA Ad Com voted against Pacira Pharmaceuticals ( PCRX ) anesthetic drug EXPAREL. HRTXs pipeline candidate HTX-011 is being ev… read more...
Your Daily Pharma Scoop: Buy Heron At Dips, Aimmune Positive Data, Voyager And AbbVie Ink Deal
via: SeekingAlpha at 2018-02-21 08:00:00:000
Analysis of top Seeking Alpha coverage: Heron Therapeutics Today we will discuss Heron Therapeutics ( HRTX ), which got a boost last week after an FDA Ad Com voted against Pacira Pharmaceuticals ( PCRX ) anesthetic drug EXPAREL. HRTXs pipeline candidate HTX-011 is being ev… read more...
Midday Gainers / Losers (2/20/2018)
via: SeekingAlpha at 2018-02-20 12:47:14:000
Gainers: FOGO +25% . VYGR +22% . DIN +21% . DCAR +21% . ACHV +19% . DPW +16% . APRI +17% . ECYT +14% . DQ +13% . AVGR +13% . More news on: Fogo de Chao, Voyager Therapeutics, Dine Brands Global, Inc., Stocks on the move, , Read more … read more...
Premarket Losers as of 9:05 am (1/25/2018)
via: SeekingAlpha at 2018-01-25 09:14:56:000
CFMS -33% on pricing stock offering at $1.50. More news on: ConforMIS, Ocular Therapeutix, Achieve Life Sciences, Inc., Stocks on the move, Read more … read more...
Premarket Losers as of 9:05 am (1/25/2018)
via: SeekingAlpha at 2018-01-25 09:14:56:000
CFMS -33% on pricing stock offering at $1.50. More news on: ConforMIS, Ocular Therapeutix, Achieve Life Sciences, Inc., Stocks on the move, Read more … read more...
Premarket Losers as of 9:05 am (1/25/2018)
via: SeekingAlpha at 2018-01-25 09:14:56:000
CFMS -33% on pricing stock offering at $1.50. More news on: ConforMIS, Ocular Therapeutix, Achieve Life Sciences, Inc., Stocks on the move, Read more … read more...
Midday Gainers / Losers (1/24/2018)
via: SeekingAlpha at 2018-01-24 12:46:54:000
Gainers: OPGN +58% . ACHV +51% . OHGI +29% . HTM +27% . SRT +20% . CERS +18% . RFIL +17% . CARA +17% . ANTH +16% . GWW +16% . More news on: OpGen, Achieve Life Sciences, Inc., One Horizon Group, Inc., Stocks on the move, Read more … read more...
Achieve Life Sciences expands partnership with the University of Bristol for Cytisine-based therapies
via: SeekingAlpha at 2018-01-24 07:26:57:000
Achieve Life Sciences (NASDAQ: ACHV ) announces an amendment to their Technology Licence Agreement with the University of Bristol, UK. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Read more … read more...
Achieve Announces Expansion of Partnership with the University of Bristol for Next Generation Cytisine-Based Therapies to Include Exclusive Rights for Cytisine Development Across Multiple Therapeutic Categories
via: PR Newswire at 2018-01-24 05:30:00:000
BOTHELL, Washington and VANCOUVER, British Columbia , Jan. 24, 2018 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced an am… read more...
Achieve Announces Clinical Trial Supply and Cooperation Agreement with the University of Auckland for the Evaluation of Cytisine Compared to Varenicline for Smoking Cessation
via: PR Newswire at 2017-11-28 05:30:00:000
BOTHELL, Wash. and VANCOUVER, British Columbia , Nov. 28, 2017 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced an agreeme… read more...
Midday Gainers / Losers
via: SeekingAlpha at 2017-11-21 12:40:19:000
Gainers: CLSN +47% . OTCPK:OMNT +33% . ACHV +26% . ATOM +25% . CADC +20% . EKSO +19% . XNET +18% . CMCM +18% . RELV +17% . CUB +15% . More news on: Celsion Corporation, Ominto, Inc., Achieve Life Sciences, Inc., Stocks on the move, Read more … read more...
Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability of Cytisine in Fed and Fasted Subjects
via: PR Newswire at 2017-11-14 05:30:00:000
BOTHELL, Wash. and VANCOUVER, British Columbia , Nov. 14, 2017 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced results of… read more...
Your Daily Pharma Scoop: Neurocrine Has Upside, Dynavax Gets FDA Nod, Sage Soars
via: SeekingAlpha at 2017-11-12 00:20:46:000
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Neurocrine Biosciences Today we will d… read more...
Achieve Reports Financial Results for Third Quarter 2017
via: PR Newswire at 2017-11-09 16:05:00:000
BOTHELL, Wash. and VANCOUVER, British Columbia , Nov. 9, 2017 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced financial result… read more...
Achieve to Present at the 29th Annual Piper Jaffray Healthcare Conference on November 28th, 2017
via: PR Newswire at 2017-11-08 05:30:00:000
BOTHELL, Wash. and VANCOUVER, British Columbia , Nov. 8, 2017 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that Rick … read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2017-08-03 | 11.0 | 1.0 | 11.0 |